DIA Value-based Pricing Bootcamp

Met korting

16/03/20

This course will outline how best to harness RWE to better understand the price, value, and impact of next generation therapies. Using RWE for comparative effectiveness

Overview

This short course will demonstrate how we can bridge this seemingly intractable pricing impasse being driven by our current system of efficacy evaluating new treatments based only on 6-9 months of mean response in a clinical trial, and provide tangible examples as to how we can harness RWE to develop workable effectiveness tools for measurement.

Target audience

This short course is designed for:

• Regulators
• Insurance (Payers) both National and Private
• HTAs
• Industry Access Managers (both Large Pharma and Biotech)
• Health IT Providers
• VCs and Fund managers
• Patient Advocates

Member discount

HollandBIO members are eligible for a 15% discount. To obtain the discount please send your registration form to: basel@diaglobal.org

More information

https://www.diaglobal.org/en/course-listing/training/2020/03/value-based-pricing-bootcamp